ANXA6
Annexin A6
Also known as: ANX6, ANXA6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08133
- Gene
- ANXA6
- Ensembl
- ENSG00000197043
- Chromosome
- 5
- Canonical length
- 673 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Transporters
- Subcellular location
- Basal body,Cytosol
OverviewNCBI Gene
Annexin VI belongs to a family of calcium-dependent membrane and phospholipid binding proteins. Several members of the annexin family have been implicated in membrane-related events along exocytotic and endocytotic pathways. The annexin VI gene is approximately 60 kbp long and contains 26 exons. It encodes a protein of about 68 kDa that consists of eight 68-amino acid repeats separated by linking sequences of variable lengths. It is highly similar to human annexins I and II sequences, each of which contain four such repeats. Annexin VI has been implicated in mediating the endosome aggregation and vesicle fusion in secreting epithelia during exocytosis. Alternatively spliced transcript variants have been described. [provided by RefSeq, Aug 2010]
Canonical amino-acid sequenceUniProt
673 residues, UniProt reviewed canonical sequence.
>P08133|ANXA6
1 MAKPAQGAKY RGSIHDFPGF DPNQDAEALY TAMKGFGSDK EAILDIITSR SNRQRQEVCQ
61 SYKSLYGKDL IADLKYELTG KFERLIVGLM RPPAYCDAKE IKDAISGIGT DEKCLIEILA
121 SRTNEQMHQL VAAYKDAYER DLEADIIGDT SGHFQKMLVV LLQGTREEDD VVSEDLVQQD
181 VQDLYEAGEL KWGTDEAQFI YILGNRSKQH LRLVFDEYLK TTGKPIEASI RGELSGDFEK
241 LMLAVVKCIR STPEYFAERL FKAMKGLGTR DNTLIRIMVS RSELDMLDIR EIFRTKYEKS
301 LYSMIKNDTS GEYKKTLLKL SGGDDDAAGQ FFPEAAQVAY QMWELSAVAR VELKGTVRPA
361 NDFNPDADAK ALRKAMKGLG TDEDTIIDII THRSNVQRQQ IRQTFKSHFG RDLMTDLKSE
421 ISGDLARLIL GLMMPPAHYD AKQLKKAMEG AGTDEKALIE ILATRTNAEI RAINEAYKED
481 YHKSLEDALS SDTSGHFRRI LISLATGHRE EGGENLDQAR EDAQVAAEIL EIADTPSGDK
541 TSLETRFMTI LCTRSYPHLR RVFQEFIKMT NYDVEHTIKK EMSGDVRDAF VAIVQSVKNK
601 PLFFADKLYK SMKGAGTDEK TLTRIMVSRS EIDLLNIRRE FIEKYDKSLH QAIEGDTSGD
661 FLKALLALCG GEDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANXA6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 315 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 315 nTPM
- tongue: 307 nTPM
- adipose tissue: 269 nTPM
- smooth muscle: 266 nTPM
- choroid plexus: 260 nTPM
- ovary: 229 nTPM
Single-cell type
- hepatic stellate cells: 310 nCPM
- syncytiotrophoblasts: 278 nCPM
- rod photoreceptor cells: 276 nCPM
- adipocytes: 233 nCPM
- peritubular myoid cells: 216 nCPM
- smooth muscle cells: 193 nCPM
Immune cell
- total PBMC: 355 nTPM
- gdT-cell: 307 nTPM
- memory CD8 T-cell: 277 nTPM
- NK-cell: 276 nTPM
- memory CD4 T-cell: 224 nTPM
- T-reg: 203 nTPM
Brain region
- choroid plexus: 244 nTPM
- cerebral cortex: 239 nTPM
- pons: 230 nTPM
- medulla oblongata: 201 nTPM
- thalamus: 193 nTPM
- hypothalamus: 188 nTPM
ReferencesPubMed · IEDB
Publications for ANXA6 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- A case of neonatal lupus erythematosus presenting delayed dilated cardiomyopathy with circulating autoantibody to annexin A6.
2007 · Int Heart J · RCR 0.3 · 12 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.64
- DepMap mean gene effect
- 0.19
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic signaling pathway
- calcium ion transport
- mitochondrial calcium ion homeostasis
- monoatomic ion transmembrane transport
- regulation of muscle contraction
- negative regulation of sequestering of calcium ion
Molecular functions
- calcium ion binding
- calcium-dependent phospholipid binding
- calcium-dependent protein binding
- cholesterol binding
- GTP binding
- identical protein binding
- ligand-gated monoatomic ion channel activity
- lipid binding
- phosphatidylserine binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ANXA6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANXA6 as an antibody target. Whether an autoantibody or antibody against ANXA6 could matter depends on whether native ANXA6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANXA6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ANXA6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...